Ming Lim With Team Highlights The Importance of Identifying NSHA Patients
Ming Lim, Clinical Associate Professor at University of Utah, shared on LinkedIn:
“Using the My Life Our Future Research Repository, we analyzed the largest known cohort of individuals with non-severe hemophilia A (NSHA) who developed inhibitors (n=142). We identified 70 distinct F8 gene variants where inhibitor development occurred in a multiethnic cohort. These findings highlight the importance of identifying NSHA patients at-risk for inhibitors to improve clinical management and outcomes.
This study took years in the making, and would not have been possible without the support of the HTRS Mentored Research Award, Nigel Key, Jill Johnsen, Kristy Lee, American Thrombosis and Hemostasis Network (ATHN) and Tammuella Chrisentery-Singleton, and the My Life Our Future Research Repository.”
Title: F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A
Authors: Ming Y. Lim, Kristy Lee, Jill M. Johnsen, Nigel S. Key

Read full article here.
Stay updated about latest Haemophilia A news with Hemostasis Today.
-
Mar 16, 2026, 07:26James Crowley, Professor of Medicine emeritus at Brown University, posted on LinkedIn:
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency